Article

Resting and active states of the ERK2:HePTP complex.

Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, Rhode Island 02912, USA.
Journal of the American Chemical Society (Impact Factor: 11.44). 11/2011; 133(43):17138-41. DOI: 10.1021/ja2075136
Source: PubMed

ABSTRACT The MAP kinase ERK2 (ERK2, extracellular signal-regulated kinase 2) is regulated by numerous phosphatases that tightly control its activity. For example, the hematopoietic tyrosine phosphatase (HePTP) negatively regulates T cell activation in lymphocytes via ERK2 dephosphorylation. However, only very limited structural information is available for these biologically important complexes. Here, we use small-angle X-ray scattering combined with EROS ensemble refinement to characterize the structures of the resting and active states of ERK2:HePTP complexes. Our data show that the resting state ERK2:HePTP complex adopts a highly extended, dynamic conformation that becomes compact and ordered in the active state complex. This work experimentally demonstrates that these complexes undergo significant dynamic structural changes in solution and provides the first structural insight into an active state MAPK complex.

0 Bookmarks
 · 
116 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The mitogen-activated protein kinase p38γ (also known as MAPK12) and its specific phosphatase PTPN3 (also known as PTPH1) cooperate to promote Ras-induced oncogenesis. We determined the architecture of the PTPN3-p38γ complex by a hybrid method combining x-ray crystallography, small-angle x-ray scattering, and chemical cross-linking coupled to mass spectrometry. A unique feature of the glutamic acid-containing loop (E-loop) of the phosphatase domain defined the substrate specificity of PTPN3 toward fully activated p38γ. The solution structure revealed the formation of an active-state complex between p38γ and the phosphatase domain of PTPN3. The PDZ domain of PTPN3 stabilized the active-state complex through an interaction with the PDZ-binding motif of p38γ. This interaction alleviated autoinhibition of PTPN3, enabling efficient tyrosine dephosphorylation of p38γ. Our findings may enable structure-based drug design targeting the PTPN3-p38γ interaction as an anticancer therapeutic.
    Science Signaling 10/2014; 7(347):ra98. DOI:10.1126/scisignal.2005722 · 7.65 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The mitogen-activated protein (MAP) kinase pathway is a validated target for anti-cancer therapy. Clinical outcomes with inhibitors of pathway effectors , B-Raf and MKK1/2, demonstrate acquired resistance via up-regulation of the kinase activity of extracellular signal-regulated kinases 1 and 2 (ERK1/2). Thus, inhibitors of ERK1/2, alone or in combination with other MAP kinase inhibitors, are potentially important therapeutic treatments for tumors with acquired resistance. The structures and potencies of different ERK inhibitors have been published, but their mechanistic and kinetic characteristics have not been compared. Here we perform kinetic studies on six representative ERK inhibitors, with potencies varying from 100 pM to 20 µM. Compounds with significant biological activity (IC50<100 nM) that inhibit in the sub-nanomolar range (Vertex-11e, SCH772984) display slow-onset inhibition and represent the first inhibitors of ERK2 known to demonstrate slow dissociation (0.2 h-1 and 1.1 h-1, respectively). By developing a kinetic competition assay, we demonstrate that Vertex-11e binds with differing affinities to inactive, unphosphorylated vs active, phosphorylated forms of ERK2. NMR HMQC measurements show that Vertex-11e favors distinct conformational states in the inactive vs active forms. Thus, a high affinity, slow dissociation inhibitor of ERK favors different enzyme conformations depending on the activity state of the kinase.
    Biochemistry 10/2014; DOI:10.1021/bi501101v · 3.38 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Structural biology elucidates atomic structures of macromolecules such as proteins, DNA, RNA, and their complexes to understand the basic mechanisms of their functions. Among proteins that pose the most difficult problems to current efforts are those which have several large domains connected by long, flexible polypeptide segments. Although abundant and critically important in biological cells, such proteins have proven intractable by conventional techniques. This gap has recently led to the advancement of hybrid methods that use state-of-the-art computational tools to combine complementary data from various high- and low-resolution experiments. In this review, we briefly discuss the individual experimental techniques to illustrate their strengths and limitations, and then focus on the use of hybrid methods in structural biology. We describe how representative structures of dynamic multi-protein complexes are obtained utilizing the EROS hybrid method that we have co-developed.
    Journal of Physics Condensed Matter 11/2014; 26(46):463103. DOI:10.1088/0953-8984/26/46/463103 · 2.22 Impact Factor

Full-text

Download
40 Downloads
Available from
May 17, 2014